At the CU Hemophilia and Thrombosis Center, we know that progress in bleeding and clotting disorders happens faster when we work together. Our team partners with researchers, healthcare providers, and community organizations around the world to bring new ideas and treatments to patients.
We welcome collaboration at every level—on campus, across the region, and internationally.
- On Campus: We work closely with providers and scientists in the Departments of Medicine, Pediatrics, and Bioengineering, as well as the Colorado Clinical & Translational Sciences Institute (CCTSI) and the Gates Institute. These partnerships combine medical insight with technology to create new tools for diagnosis and treatment of bleeding and clotting disorders.
- Regional & National: As part of the Mountain States Hemophilia Network and the American Thrombosis & Hemostasis Network (ATHN), we share data, participate in national registries, and help lead multi-center studies supported by the CDC, NIH, and industry partners.
- International: We contribute to global studies on rare bleeding and clotting disorders and host visiting clinicians and scientists interested who wish to learn from our experts. Our investigators also help shape international guidelines that improve care for patients everywhere.
Whether you’re a scientist, clinician, or organization, we invite you to collaborate with us. Contact our Scientific Director, Keith Neeves with inquiries.